Literature DB >> 1281641

Multiple sclerosis: an autoimmune disease of multifactorial etiology.

C C Bernard1, N Kerlero de Rosbo.   

Abstract

The etiology of multiple sclerosis is linked to a variety of genetic and environmental factors. Both cell-mediated and humoral immune responses, triggered by extraneous or autoantigens, are likely to contribute to the pathogenesis of this disease. A greater insight into the fundamental cause of multiple sclerosis has been provided by the recognition that certain immune response genes are associated with an increased susceptibility to the disease. Such knowledge should provide new opportunities for selective therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281641     DOI: 10.1016/0952-7915(92)90058-m

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

Review 1.  New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  R Arnon; M Sela; D Teitelbaum
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

2.  Changes in concanavalin A-reactive proteins in neurological disorders.

Authors:  L Saso; G Valentini; M G Leone; E Grippa; R Guglielmi; L Paris; G Cantore; B Silvestrini
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 3.  Selective targeting of the immune response in autoimmune demyelination.

Authors:  J R Oksenberg
Journal:  West J Med       Date:  1994-09

4.  Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

Authors:  J L McQualter; R Darwiche; C Ewing; M Onuki; T W Kay; J A Hamilton; H H Reid; C C Bernard
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

5.  The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice.

Authors:  Saideh Fakharzadeh; Mohammad Ali Sahraian; Maryam Hafizi; Somayeh Kalanaky; Zahra Masoumi; Mehdi Mahdavi; Nasser Kamalian; Alireza Minagar; Mohammad Hassan Nazaran
Journal:  Int J Nanomedicine       Date:  2014-08-11

Review 6.  Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options.

Authors:  Jasna Jancic; Blazo Nikolic; Nikola Ivancevic; Vesna Djuric; Ivan Zaletel; Dejan Stevanovic; Sasa Peric; John N van den Anker; Janko Samardzic
Journal:  Neurol Ther       Date:  2016-09-17

Review 7.  Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?

Authors:  Matías Sáenz-Cuesta; Iñaki Osorio-Querejeta; David Otaegui
Journal:  Front Cell Neurosci       Date:  2014-03-28       Impact factor: 5.505

8.  Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.

Authors:  Conan K Wang; Christian W Gruber; Maša Cemazar; Christopher Siatskas; Prascilla Tagore; Natalie Payne; Guizhi Sun; Shunhe Wang; Claude C Bernard; David J Craik
Journal:  ACS Chem Biol       Date:  2013-11-07       Impact factor: 5.100

Review 9.  Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis.

Authors:  G L Stoner
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

10.  Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.

Authors:  Thomas Breakell; Sabine Tacke; Verena Schropp; Henrik Zetterberg; Kaj Blennow; Eduard Urich; Stefanie Kuerten
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.